Please use this identifier to cite or link to this item:
|Title:||Hypophysitis following Treatment with Ustekinumab: Radiological and Pathological Findings.|
|Citation:||Front Endocrinol (Lausanne).2018;(9):83|
|Abstract:||Ustekinumab is a human IgG1 monoclonal antibody that targets interleukin (IL)-12 and IL-23, which may be useful in the treatment of autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn's disease. Hypophysitis is an immune-derived inflammatory condition of the pituitary gland that may lead to pituitary dysfunction. With the increasing use of immunotherapy, it is possible that this and other new immune-related adverse events (IRAEs) arise, although the mechanisms involved are still incompletely defined.|
|Appears in Collections:||Hospitales > H. U. Infanta Leonor > Artículos|
Fundaciones e Institutos de Investigación > IIS H. U. La Princesa > Artículos
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.